4.6 Meeting Abstract

CARDIOMETABOLIC OUTCOMES OF SITAGLIPTIN-ENHANCED METFORMIN TREATMENT IN UNCONTROLLED TYPE 2 DIABETES PATIENTS WITHOUT ATHEROSCLEROTIC MANIFESTATIONS

Journal

ATHEROSCLEROSIS
Volume 379, Issue -, Pages S101-S102

Publisher

ELSEVIER IRELAND LTD

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available